This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mylan Laboratories Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Katukuri Aravind Kumar: Innovator in Pharmaceutical Processes
Introduction
Katukuri Aravind Kumar is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of important compounds. His work exemplifies the innovative spirit that drives advancements in medicine and healthcare.
Latest Patents
Katukuri Aravind Kumar holds a patent for a process titled "Process for preparing pure valsartan." This patent describes an improved method for the preparation of substantially pure valsartan using suitable reagents, including a chelating agent and specific reaction conditions. This innovation is crucial for enhancing the quality and efficacy of valsartan, a medication used to treat high blood pressure and heart failure.
Career Highlights
Aravind Kumar is currently employed at Mylan Laboratories Limited, a global leader in generic and specialty pharmaceuticals. His role at Mylan allows him to apply his expertise in pharmaceutical processes and contribute to the development of high-quality medications. His dedication to innovation in this field is evident through his patent and ongoing work.
Collaborations
He has collaborated with talented coworkers such as Om Dutt Tyagi and Jakka Devendra Rao. These partnerships have likely fostered a creative environment that encourages the development of new ideas and solutions in pharmaceutical sciences.
Conclusion
Katukuri Aravind Kumar is a distinguished inventor whose work in the pharmaceutical industry has led to significant advancements in drug preparation processes. His contributions, particularly in the development of pure valsartan, highlight the importance of innovation in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
